Truist Securities analyst Robyn Karnauskas maintains Gilead Sciences (NASDAQ:GILD) with a Hold and raises the price target from $71 to $76.
Kratos Secures $54M Task Order To Develop Low Cost, Limited Life Engine For Attritable And Expendable Systems
Kratos Defense & Security Solutions, Inc’s (NASDAQ:KTOS) division Kratos Turbine Technologies (KTT) Division, has been awarded a task order contract to…